These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 1673233

  • 1. [The effects of bisoprolol and atenolol on glucose metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus].
    Vulpis V, Antonacci A, Prandi P, Bokor D, Pirrelli A.
    Minerva Med; 1991 Apr; 82(4):189-93. PubMed ID: 1673233
    [Abstract] [Full Text] [Related]

  • 2. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H, Schmidt J, Derendorf H.
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [Abstract] [Full Text] [Related]

  • 3. Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects.
    Feher MD, Henderson AD, Wadsworth J, Poulter C, Gelding S, Richmond W, Sever PS, Elkeles RS.
    J Hum Hypertens; 1990 Oct; 4(5):571-7. PubMed ID: 1980930
    [Abstract] [Full Text] [Related]

  • 4. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
    Kukes VG, Ostroumova OD, Mamaev VI, Batutina AM, Abakumov IuE, Zykova AA.
    Ter Arkh; 2003 Mar; 75(8):43-7. PubMed ID: 14520850
    [Abstract] [Full Text] [Related]

  • 6. A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension.
    Wheeldon NM, MacDonald TM, Prasad N, Maclean D, Peebles L, McDevitt DG.
    QJM; 1995 Aug; 88(8):565-70. PubMed ID: 7648243
    [Abstract] [Full Text] [Related]

  • 7. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
    Colnago R, Meregalli M, Turri D, Nazzari M, Fiorella G, Guffanti EE, Mazzola C.
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
    [Abstract] [Full Text] [Related]

  • 8. [Atenolol and bisoprolol in the treatment of mild and moderately severe hypertension].
    Soucek M, Prásek J, Spinarová L.
    Vnitr Lek; 1993 Jun; 39(6):541-8. PubMed ID: 8212607
    [Abstract] [Full Text] [Related]

  • 9. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P, Thalhofer S, Bethge H, Disselhoff G, Wagner G.
    J Cardiovasc Pharmacol; 1990 Jun; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [Abstract] [Full Text] [Related]

  • 10. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T, Lehtonen A.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [Abstract] [Full Text] [Related]

  • 11. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM, Rabot D, Herrero G.
    J Cardiovasc Pharmacol; 1990 Jun; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [Abstract] [Full Text] [Related]

  • 12. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O.
    J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
    [Abstract] [Full Text] [Related]

  • 13. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O, Rydén L.
    Acta Med Scand; 1981 Aug; 209(4):261-6. PubMed ID: 7015797
    [Abstract] [Full Text] [Related]

  • 14. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N.
    Eur J Med Res; 2003 Jul 31; 8(7):295-303. PubMed ID: 12911866
    [Abstract] [Full Text] [Related]

  • 15. [Efficacy and tolerability of a cardioselective beta-blocking drug (atenolol) in the treatment of essential hypertension. A double blind study (author's transl)].
    Rengo F, Trimarco B, Petretta M, Ferrara N, Bonaduce D, Chiariello M, Condorelli M.
    G Ital Cardiol; 1978 Jul 31; 8(8):861-7. PubMed ID: 359398
    [Abstract] [Full Text] [Related]

  • 16. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ, Hermann F, Wiesli P, Schwegler B, Chenevard R, Hürlimann D, Sudano I, Gay S, Neidhart M, Riesen W, Ruschitzka F, Lüscher TF, Noll G, Lehmann R.
    J Hypertens; 2007 Apr 31; 25(4):785-91. PubMed ID: 17351370
    [Abstract] [Full Text] [Related]

  • 17. Casual versus ambulatory twenty-four-hour blood pressure measurement in a comparative study with bisoprolol or nitrendipine.
    Mengden T, Schubert M, Jeck T, Edmonds D, Vetter W.
    J Hypertens Suppl; 1990 Sep 31; 8(4):S91-4. PubMed ID: 1979615
    [Abstract] [Full Text] [Related]

  • 18. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH, Davies RA, Fourney A.
    Clin Pharmacol Ther; 1998 Nov 31; 64(5):522-35. PubMed ID: 9834044
    [Abstract] [Full Text] [Related]

  • 19. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
    Giugliano D, Acampora R, Marfella R, De Rosa N, Ziccardi P, Ragone R, De Angelis L, D'Onofrio F.
    Ann Intern Med; 1997 Jun 15; 126(12):955-9. PubMed ID: 9182472
    [Abstract] [Full Text] [Related]

  • 20. [The effect long-term administration of a selective beta1 blocker bisoprolol on glucose metabolism in patients with essential hypertensive and type 2 diabetes mellitus].
    Wang B, Song WH, Liu GZ, Multi-center Cooperation Group of Bisoprolol.
    Zhonghua Nei Ke Za Zhi; 2005 Jul 15; 44(7):503-5. PubMed ID: 16080839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.